Appetite Regulation
3 articles on Appetite Regulation, written by Shotlee and medically reviewed for clinical accuracy.
ARD-201 Trial: Maintaining Weight Loss After Ozempic, Wegovy
GLP-1 drugs like Ozempic and Wegovy deliver impressive weight loss, but regain is common after stopping. A new Phase 2 trial of oral ARD-201 aims to change that by regulating appetite via bitter taste receptors. Led by obesity expert Lawrence Cheskin at George Mason University, this study targets post-treatment weight maintenance.
5 min read
GLP-1 RAs Reduce Food Noise by 46%, Emerging Evidence Shows
Emerging evidence suggests GLP-1 receptor agonists (GLP-1 RAs) not only aid weight loss but also significantly quiet 'food noise'—those persistent, distressing thoughts about food. In the US-based INFORM survey, 550 individuals using GLP-1s reported a 46% reduction in constant food thoughts, alongside mental health gains. This could redefine obesity management for better holistic outcomes.
6 min read
Founder Targets $50B GLP-1 Market with Natural Alternative
In a $50 billion GLP-1 market dominated by injectables like Ozempic, Becca McCarthy is carving out space with Evolv—a natural pill for appetite control. Teaming with a molecular biologist, she's delivering GLP-1-like effects without stigma or synthetics. Here's how she's challenging the prescription-only model.
5 min read